Engineered PEG–PCL nanoparticles enable sensitive and selective detection of sodium dodecyl sulfate: a qualitative and quantitative analysis

• Soni Prajapati and
• Ranjana Singh

Beilstein J. Nanotechnol. 2025, 16, 385–396, doi:10.3762/bjnano.16.29

• been designated as a generally recognized safe (GRAS) ingredient for food applications by the United States Food and Drug Administration (USFDA), as stipulated in 21 CFR 172.822. This anionic surfactant serves dual functions in food processing: as an emulsifying agent and a whipping aid [13]. The

• manipulation of particles with a size less than 100 nm. These tiny particles possess unique physicochemical features, including optical, electrical, magnetic, and catalytic properties [23]. Indeed, the advanced properties of nanoparticles enables them to be used in different areas, such as biosensing, drug

• nanoparticles is a step ahead of the reported studies. Polymer nanoparticles prepared from PEG–PCL are widely used for drug delivery, tumour targeting, and imaging [28]. To our knowledge, there is no report regarding using PEG–PCL nanoparticles (PEG–PCL NPs) as a contaminant detection system. Accordingly, we

Development of a mucoadhesive drug delivery system and its interaction with gastric cells

• Ahmet Baki Sahin,
• Serdar Karakurt and
• Deniz Sezlev Bilecen

Beilstein J. Nanotechnol. 2025, 16, 371–384, doi:10.3762/bjnano.16.28

• mucoadhesive drug delivery system that was developed to fulfill these requirements. Alginate nanoparticles were synthesized by water-in-oil emulsification followed by external gelation and then coated with the mucoadhesive polymer Eudragit RS100. The formulated nanoparticles had a mean size of 219 nm and

• positive charge. A peptide, as a model drug, was loaded onto the nanoparticles with an encapsulation efficiency of 58%. The release of the model drug from the delivery system was pH-independent and lasted for 7 days. The periodic acid–Schiff stain assay indicated 69% mucin interaction for the nanoparticles

• developed in this study is intended to be loaded with active therapeutic agents and has the potential to be used as an alternative drug delivery strategy for the treatment of gastric related diseases. Keywords: alginate; Eudragit RS100; mucoadhesive nanoparticles; mucus; smart drug delivery; Introduction

Graphene oxide–chloroquine conjugate induces DNA damage in A549 lung cancer cells through autophagy modulation

• Braham Dutt Arya,
• Sandeep Mittal,
• Prachi Joshi,
• Alok Kumar Pandey,
• Jaime E. Ramirez-Vick,
• Govind Gupta and
• Surinder P. Singh

Beilstein J. Nanotechnol. 2025, 16, 316–332, doi:10.3762/bjnano.16.24

• capabilities of cancer cells. The results indicate that the interplay between DDR and autophagy pathways may open new paradigms for developing effective combinatorial nanoscale drug systems against multidrug-resistance cancers. Keywords: A549 cells; autophagy; chloroquine; DNA damage; graphene oxide

• ; nanoconjugates; SQSTM1/p62; Introduction Despite of advances in basic and clinical research, an increased mortality rate is seen worldwide in cancer-associated deaths [1]. The heterogeneous and complex tumor microenvironment along with intrinsic and/or acquired drug resistance mechanisms, such as increased drug

• efflux, DNA damage repair, and activation of pro-survival cell signaling cascades, alterations in drug target moieties limit the effectiveness of chemotherapeutic treatments [2][3]. In general, chemotherapeutic drugs inhibit the cancer progression and metastases by directly or indirectly targeting DNA of

Fabrication and evaluation of BerNPs regarding the growth and development of Streptococcus mutans

• Tuyen Huu Nguyen,
• Hong Thanh Pham,
• Kieu Kim Thanh Nguyen,
• Loan Hong Ngo,
• Anh Ngoc Tuan Mai,
• Thu Hoang Anh Lam,
• Ngan Thi Kim Phan,
• Dung Tien Pham,
• Duong Thuy Hoang,
• Thuc Dong Nguyen and
• Lien Thi Xuan Truong

Beilstein J. Nanotechnol. 2025, 16, 308–315, doi:10.3762/bjnano.16.23

• plaque formation associated with caries damage. Therefore, one of the initial steps in preventing dental caries is to reduce and inhibit the activity of S. mutans in the oral cavity [8]. Tooth decay and oral infections are typically controlled with antibiotics. However, the proliferation of drug

Enhancing mechanical properties of chitosan/PVA electrospun nanofibers: a comprehensive review

• Nur Areisman Mohd Salleh,
• Amalina Muhammad Afifi,
• Fathiah Mohamed Zuki and
• Hanna Sofia SalehHudin

Beilstein J. Nanotechnol. 2025, 16, 286–307, doi:10.3762/bjnano.16.22

• loaded with ampicillin sodium for burst drug release, and glutaraldehyde was applied as chemical cross-link to the nanofibers [139]. This treatment produced fine morphology and enhanced mechanical properties. The Young’s modulus improved from 36.5 to 198.1 MPa, and the tensile strength increased from 2.2

• efficient sustained release. These nanofibers also exhibit better stability, which are vital properties in drug delivery systems [183][184]. These superior properties have gained recent attention for enhancing the functional performance of chitosan-based nanofibers. Core–shell chitosan nanofibers have been

• utilized in various specialized applications, such as scaffolds in tissue engineering [185], controlling drug release mechanisms through the manipulation of core and shell compositions [186], and protecting sensitive biomolecules in food packaging [187]. The combination of core–shell chitosan-based

Radiosensitizing properties of dual-functionalized carbon nanostructures loaded with temozolomide

• Radmila Milenkovska,
• Nikola Geskovski,
• Dushko Shalabalija,
• Ljubica Mihailova,
• Petre Makreski,
• Dushko Lukarski,
• Igor Stojkovski,
• Maja Simonoska Crcarevska and
• Kristina Mladenovska

Beilstein J. Nanotechnol. 2025, 16, 229–251, doi:10.3762/bjnano.16.18

• , temozolomide (TMZ), a drug used for the treatment of anaplastic astrocytoma and glioblastoma multiforme (GBM), was incorporated into multiwalled carbon nanotubes (MWCNTs) and a MWCNTs–graphene (MWCNTs-G) hybrid compound, covalently functionalized with polyethylene glycol (PEG) 6000 and folic acid (FA), with an

• aim to prepare nanocarriers with the potential to prolong the drug circulation time, cross the blood–brain–tumor barrier (BBTB), and provide targeted and controlled drug release in the brain tumor cells. Cytotoxicity and effects on cell membrane integrity of the blank and TMZ-loaded dual

• changes in the structure of the CNs and TMZ after irradiation were observed. With single and dual functionalization, formulations with relatively high TMZ loading efficiency and drug content were prepared. They exhibited homogeneous particle size distributions and mean particle sizes and surface charges

Synthesis and the impact of hydroxyapatite nanoparticles on the viability and activity of rhizobacteria

• Bedah Rupaedah,
• Indrika Novella,
• Atiek Rostika Noviyanti,
• Diana Rakhmawaty Eddy,
• Anna Safarrida,
• Abdul Hapid,
• Zhafira Amila Haqqa,
• Suryana Suryana,
• Irwan Kurnia and
• Fathiyah Inayatirrahmi

Beilstein J. Nanotechnol. 2025, 16, 216–228, doi:10.3762/bjnano.16.17

• ]. nHA serves as a versatile agent in drug delivery [17], acts as a carrier for genes and proteins [18], and aids in immobilizing rhizobacteria for effective heavy metal removal [19]. In addition to its carrier capabilities, nHA exhibits exceptional attributes such as high biodegradability

Recent advances in photothermal nanomaterials for ophthalmic applications

• Jiayuan Zhuang,
• Linhui Jia,
• Chenghao Li,
• Rui Yang,
• Jiapeng Wang,
• Wen-an Wang,
• Heng Zhou and
• Xiangxia Luo

Beilstein J. Nanotechnol. 2025, 16, 195–215, doi:10.3762/bjnano.16.16

• boundaries of thermal therapy, achieving unparalleled therapeutic effects through their diverse composite structures and demonstrating enormous potential in promoting retinal drug delivery and photoacoustic imaging. This paper provides a comprehensive summary of the structure–activity relationship between

• clinical adoption of anti-vascular endothelial growth factor drugs and laser therapy [3][4]. Despite these strides, challenges remain in effectively addressing complex ophthalmic issues, particularly in underprivileged areas where high costs associated with precision optical diagnostics and advanced drug

• (Figure 1). In addition, the application progress of photothermal nanomaterials in promoting retinal drug delivery and enhancing photoacoustic imaging was also discussed. Finally, we address the current challenges and prospects in ophthalmic treatment technologies based on photothermal nanomaterials, with

Probing the potential of rare earth elements in the development of new anticancer drugs: single molecule studies

• Josiane A. D. Batista,
• Rayane M. de Oliveira,
• Carlos H. M. Lima,
• Milton L. Lana Júnior,
• Virgílio C. dos Anjos,
• Maria J. V. Bell and
• Márcio S. Rocha

Beilstein J. Nanotechnol. 2025, 16, 187–194, doi:10.3762/bjnano.16.15

• interdisciplinary research to find, produce, and test drug candidates until they can reach the market [1][2]. Cancer chemotherapy, for instance, is a type of treatment that deserves improvements not only in the efficacy of the drugs employed to kill tumor cells, but also in reducing the occurrence of the well-known

• side effects related to these therapies. Actually, both aspects depend on the development of new drugs and/or drug carriers that can improve the selectivity of these anticancer agents to reach their specific targets inside tumor cells [3][4][5]. Although commonly used in a number of technological

• , depending on the concentration used, two of the rare earths (erbium and neodymium) tested also present the ability to compact/condense DNA, which opens the door for other types of applications such as gene therapies and the design of drug carriers themselves. To achieve such results, we performed single

Nanocarriers and macrophage interaction: from a potential hurdle to an alternative therapeutic strategy

• Naths Grazia Sukubo,
• Paolo Bigini and
• Annalisa Morelli

Beilstein J. Nanotechnol. 2025, 16, 97–118, doi:10.3762/bjnano.16.10

• .16.10 Abstract In the coming decades, the development of nanocarriers (NCs) for targeted drug delivery will mark a significant advance in the field of pharmacology. NCs can improve drug solubility, ensure precise distribution, and enable passage across biological barriers. Despite these potential

• delve into the intriguing potential of nanomedicine in neurology and traumatology, associated with macrophage interaction, and the exciting possibilities it holds for the future. Keywords: drug delivery; macrophages; nanomedicine; polarization; RNA-based therapies; Review 1 Introduction In the vast

• nanomedicine landscape, the design and development of nanocarriers (NCs) for precise drug delivery are a pivotal innovation. NCs address significant pharmacological challenges, such as enhancing drug solubility, ensuring specific distribution, and facilitating the crossing of biological barriers [1]. Tailoring

Characterization of ZnO nanoparticles synthesized using probiotic Lactiplantibacillus plantarum GP258

• Prashantkumar Siddappa Chakra,
• Aishwarya Banakar,
• Shriram Narayan Puranik,
• Vishwas Kaveeshwar,
• C. R. Ravikumar and
• Devaraja Gayathri

Beilstein J. Nanotechnol. 2025, 16, 78–89, doi:10.3762/bjnano.16.8

• typhi (3 ± 1 mm). MTT assay revealed the promising antiproliferative potential of ZnO NPs, with an average IC50 value of 98.53 µg/mL. Additionally, the NPs were photocatalytically and electrochemically analyzed, indicating their potential use in cancer research as well as in coating and drug delivery

• semiconductors. Also, ZnO NPs exhibit antimicrobial activity, targeted drug delivery, catalytic activity, and antidiabetic, larvicidal, acaricidal and anticancer activity in addition to their usage in different medical devices and pharmaceuticals [11][12][13]. We report the ecologically safe production of ZnO

• the tendency to develop drug resistance, such as MRSA or VRSA [26]. In this context, nanoparticles are perhaps an alternative strategy to control the spread of drug-resistant bacteria. Additionally, research conducted by El-Khawaga et al. [27] showed that ZnO NPs produced by Saccharomyces cerevisiae

Theoretical study of the electronic and optical properties of a composite formed by the zeolite NaA and a magnetite cluster

• Joel Antúnez-García,
• Roberto Núñez-González,
• Vitalii Petranovskii,
• H’Linh Hmok,
• Armando Reyes-Serrato,
• Fabian N. Murrieta-Rico,
• Mufei Xiao and
• Jonathan Zamora

Beilstein J. Nanotechnol. 2025, 16, 44–53, doi:10.3762/bjnano.16.5

• development of nanotechnology and the emergence of composite zeolite materials have opened up unprecedented opportunities for their application in nanomedicine [47]. The unique properties of magnetic nanoparticles allow them to be used for targeted drug delivery and visualization of internal organs [48

• Safe” [50] by the United States Food and Drug Administration [51]. Also, iron-based magnetic compounds have the advantage of being a widely available and relatively cheap material, as well as being biocompatible and environmentally friendly [52][53]. While the potential of magnetic clusters to impart

A nanocarrier containing carboxylic and histamine groups with dual action: acetylcholine hydrolysis and antidote atropine delivery

• Elina E. Mansurova,
• Andrey A. Maslennikov,
• Anna P. Lyubina,
• Alexandra D. Voloshina,
• Irek R. Nizameev,
• Marsil K. Kadirov,
• Anzhela A. Mikhailova,
• Polina V. Mikshina,
• Albina Y. Ziganshina and
• Igor S. Antipin

Beilstein J. Nanotechnol. 2025, 16, 11–24, doi:10.3762/bjnano.16.2

• antidote delivery systems that will release the drug only when acetylcholine levels are elevated. This approach will ensure timely delivery of the antidote and minimize side effects associated with uncontrolled drug release. Here, we describe the creation of a new smart system that serves as a carrier for

• , vomiting, and other serious issues [1]. ACh overproduction usually results from a malfunction of the cholinesterase enzyme caused by poisoning or medication [2][3]. Drug dosage regulation can greatly lower cholinergic toxicity [4], but the risks associated with poisoning are far higher. Poisons cause

• calixarenes, have been extensively utilized in the creation of different smart systems [13][14]. Owing to their unique structural features, these macrocycles are employed in catalysis, such as in the breakdown of OPs [15][16][17][18], as carriers for drug delivery [19][20][21][22], and in the creation of

Mechanistic insights into endosomal escape by sodium oleate-modified liposomes

• Ebrahim Sadaqa,
• Satrialdi,
• Fransiska Kurniawan and
• Diky Mudhakir

Beilstein J. Nanotechnol. 2024, 15, 1667–1685, doi:10.3762/bjnano.15.131

• .15.131 Abstract Endosomal entrapment significantly limits the efficacy of drug delivery systems. This study investigates sodium oleate-modified liposomes (SO-Lipo) as an innovative strategy to enhance endosomal escape and improve cytosolic delivery in 4T1 triple-negative breast cancer cells. We aimed to

• mechanism, facilitating cytosolic delivery with reduced cytotoxicity. This approach offers a safer and more effective option for targeted drug delivery applications. Keywords: Aurein 1.2; endosomal escape; fusogenic effect; molecular dynamics simulation; sodium oleate; Introduction The quest for efficient

• drug delivery has spurred extensive research into liposomal systems. These vesicles, with their inherent ability to encapsulate and protect a diverse range of therapeutic agents, including small molecule drugs, proteins, and genetic material such as DNA and RNA, hold significant promise for

Biomimetic nanocarriers: integrating natural functions for advanced therapeutic applications

• Hugo Felix Perini,
• Beatriz Sodré Matos,
• Carlo José Freire de Oliveira and
• Marcos Vinicius da Silva

Beilstein J. Nanotechnol. 2024, 15, 1619–1626, doi:10.3762/bjnano.15.127

• Biomimetic nanocarriers, engineered to mimic the characteristics of native cells, offer a revolutionary approach in the treatment of various complex human diseases. This strategy enhances drug delivery by leveraging the innate properties of cellular components, thereby improving biocompatibility and

• targeting specificity. Biomimetic nanocarriers demonstrate significant advancements in drug delivery systems against cancer therapy, Alzheimer's disease, autoimmune diseases, and viral infections such as COVID-19. Here, we address the therapeutic applications of biomimetic nanocarriers and their promising

• strategy for personalized medicine. Keywords: cancer; drug delivery; human health; mimetics; nanotechnology; Introduction Human exposure to nanoparticles has naturally occurred for millennia, with a notable intensification following the industrial revolution [1]. The foundational concept of modern

Natural nanofibers embedded in the seed mucilage envelope: composite hydrogels with specific adhesive and frictional properties

• Agnieszka Kreitschitz and
• Stanislav N. Gorb

Beilstein J. Nanotechnol. 2024, 15, 1603–1618, doi:10.3762/bjnano.15.126

• ], on monomer and cross-linking concentrations, and on the type of substrate surface [88]. Hydrogels with their low friction are crucial in biomedical applications or for drug delivery [38][83][86][88]. The diaspore mucilage is regarded as a natural hydrogel [38] because of its capacity to absorb water

Liver-targeting iron oxide nanoparticles and their complexes with plant extracts for biocompatibility

• Shushanik A. Kazaryan,
• Seda A. Oganian,
• Gayane S. Vardanyan,
• Anatolie S. Sidorenko and
• Ashkhen A. Hovhannisyan

Beilstein J. Nanotechnol. 2024, 15, 1593–1602, doi:10.3762/bjnano.15.125

• (Fe3O4 NPs) are widely used in many biomedical applications (e.g., bioimaging, drug delivery, biosensors, diagnostics, and theranostics). However, the use of NPs does not preclude the possibility of selective toxicity and undesirable effects, including accumulation in tissues and direct interaction with

• , biochemistry, biophysics, and other disciplines within biology and medicine [1][2][3][4][5]. The development of nanotechnology has provided resources for various applications in the medical field, leading to significant advances in diagnosis, biological detection, therapy, and drug delivery [6][7][8][9]. An

• Fe3O4 NPs have great potential for commercial use and have already found applications in biomedicine, such as magnetic resonance imaging (as contrast enhancement agents), targeted drug or gene delivery, tissue engineering, biological fluid detoxification, hyperthermia, biological sensing, nanozymes, and

Facile synthesis of size-tunable L-carnosine-capped silver nanoparticles and their role in metal ion sensing and catalytic degradation of p-nitrophenol

• Akash Kumar,
• Ridhima Chadha,
• Abhishek Das,
• Nandita Maiti and
• Rayavarapu Raja Gopal

Beilstein J. Nanotechnol. 2024, 15, 1576–1592, doi:10.3762/bjnano.15.124

• Akash Kumar Ridhima Chadha Abhishek Das Nandita Maiti Rayavarapu Raja Gopal Nanomaterial Toxicology Laboratory, Drug and Chemical Toxicology Group, Food, Drug and Chemical, Environment and Systems Toxicology (FEST) Divison, CSIR-Indian Institute of Toxicology Research (CSIR-IITR), Vishvigyan

The round-robin approach applied to nanoinformatics: consensus prediction of nanomaterials zeta potential

• Dimitra-Danai Varsou,
• Arkaprava Banerjee,
• Joyita Roy,
• Kunal Roy,
• Giannis Savvas,
• Haralambos Sarimveis,
• Ewelina Wyrzykowska,
• Mateusz Balicki,
• Tomasz Puzyn,
• Georgia Melagraki,
• Iseult Lynch and
• Antreas Afantitis

Beilstein J. Nanotechnol. 2024, 15, 1536–1553, doi:10.3762/bjnano.15.121

• Dimitra-Danai Varsou Arkaprava Banerjee Joyita Roy Kunal Roy Giannis Savvas Haralambos Sarimveis Ewelina Wyrzykowska Mateusz Balicki Tomasz Puzyn Georgia Melagraki Iseult Lynch Antreas Afantitis NovaMechanics MIKE, Piraeus 18545, Greece Entelos Institute, Larnaca 6059, Cyprus Drug Theoretics and

• ; read-across; QSPR; round-robin test; zeta potential; Introduction Nanotechnology, defined as the ability to manipulate matter at the nanoscale, has opened an array of possibilities for multiple applications that take advantage of the unique properties of nanomaterials (NMs). From targeted drug

Polymer lipid hybrid nanoparticles for phytochemical delivery: challenges, progress, and future prospects

• Iqra Rahat,
• Pooja Yadav,
• Aditi Singhal,
• Mohammad Fareed,
• Jaganathan Raja Purushothaman,
• Mohammed Aslam,
• Raju Balaji,
• Sonali Patil-Shinde and
• Md. Rizwanullah

Beilstein J. Nanotechnol. 2024, 15, 1473–1497, doi:10.3762/bjnano.15.118

• crucial for maintaining therapeutic drug levels over extended periods of time [20][21]. By adjusting the polymer composition and lipid matrix, researchers can fine-tune the release kinetics of phytochemicals, ensuring sustained therapeutic effects. This controlled release mechanism is particularly

• , gut microbiota, and individual genetic differences. This variability leads to inconsistent therapeutic outcomes among different individuals, and food–drug interactions can further complicate dosing regimens and efficacy [32][33]. Further, conventional delivery methods often lack specificity, resulting

• problematic for chronic conditions that require consistent drug exposure over extended periods of time [36][37]. Therefore, there is a need for innovative delivery systems that improve solubility, stability, bioavailability, and targeted delivery, while also providing controlled release. PLHNPs represent a

Nanotechnological approaches for efficient N2B delivery: from small-molecule drugs to biopharmaceuticals

• Selin Akpinar Adscheid,
• Akif E. Türeli,
• Nazende Günday-Türeli and
• Marc Schneider

Beilstein J. Nanotechnol. 2024, 15, 1400–1414, doi:10.3762/bjnano.15.113

• drugs can be encapsulated into various drug delivery systems to enhance physicochemical characteristics and targeting success. Many preclinical data show that this strategy can effectively deliver biopharmaceuticals to the brain. Therefore, this review focuses on N2B delivery while giving examples of

• different drug delivery systems suitable for the applications. In addition, we emphasize the importance of the effective delivery of monoclonal antibodies and RNA and stress the recent literature tackling this challenge. While giving examples of nanotechnological approaches for the effective delivery of

• small or large molecules from the current literature, we highlight the preclinical studies and their results to prove the strategies’ success and limitations. Keywords: antibody delivery; biopharmaceutical delivery; blood–brain barrier (BBB); CNS diseases; drug delivery; hybrid nanoparticles

Green synthesis of carbon dot structures from Rheum Ribes and Schottky diode fabrication

• Muhammed Taha Durmus and
• Ebru Bozkurt

Beilstein J. Nanotechnol. 2024, 15, 1369–1375, doi:10.3762/bjnano.15.110

• range of uses in the fields of electrocatalysis, bioimaging, chemical sensors, biosensors, nanomedicine, biomolecule/drug release, light-emitting diodes, and photocatalysts. They also have promising applications in areas such as lasers and optoelectronic device applications [2][3][4][5]. CDs can be

Hymenoptera and biomimetic surfaces: insights and innovations

• Vinicius Marques Lopez,
• Carlo Polidori and
• Rhainer Guillermo Ferreira

Beilstein J. Nanotechnol. 2024, 15, 1333–1352, doi:10.3762/bjnano.15.107

• biodiversity, and assessing environmental impacts, providing researchers with valuable data while preserving natural habitats. Delivery systems: Strength and efficiency of the ovipositor also offer insights into creating advanced drug delivery systems [169]. These systems can deliver medications directly to

• delivery system (Figure 7C,D). The venom delivery systems of Hymenoptera are precise and efficient, inspiring the design of microinjection systems and targeted drug delivery methods that minimize collateral damage to surrounding tissues [170]. Drawing inspiration from the precision and efficiency of

• could greatly benefit from innovations inspired by these stridulation mechanisms. Ultrasound technology has demonstrated significant potential in diagnostic imaging and ultrasound-responsive drug delivery [181][182]. Ultrasound technology is particularly promising for cancer treatment and disease

Nanoarchitectonics with cetrimonium bromide on metal nanoparticles for linker-free detection of toxic metal ions and catalytic degradation of 4-nitrophenol

• Akash Kumar and
• Raja Gopal Rayavarapu

Beilstein J. Nanotechnol. 2024, 15, 1312–1332, doi:10.3762/bjnano.15.106

• Akash Kumar Raja Gopal Rayavarapu Nanomaterial Toxicology Laboratory, Drug and Chemical Toxicology Group, Food, Drug and Chemical, Environment and Systems Toxicology (FEST) Divison, CSIR-Indian Institute of Toxicology Research (CSIR-IITR), Vishvigyan Bhawan, 31 Mahatma Gandhi Marg, Lucknow 226001

Dual-functionalized architecture enables stable and tumor cell-specific SiO₂NPs in complex biological fluids

• Iris Renata Sousa Ribeiro,
• Raquel Frenedoso da Silva,
• Romênia Ramos Domingues,
• Adriana Franco Paes Leme and
• Mateus Borba Cardoso

Beilstein J. Nanotechnol. 2024, 15, 1238–1252, doi:10.3762/bjnano.15.100

• anticancer nanomedicines are administered intravenously. This route is fast and precise as the drug enters directly into the systemic circulation, without undergoing absorption processes. When nanoparticles come into direct contact with the blood, however, they interact with physiological components that can